logo

For the Inventor, By the Inventor

Paoli, PA, United States of America

Meier E Freed

USPTO Granted Patents = 34

Average Co-Inventor Count = 1.7

ph-index = 9

Forward Citations = 195(Granted Patents)


Location History:

  • Paoli, PA (US) (1976 - 1987)
  • Bryn Mawr, PA (US) (1988)

Company Filing History:

goldMedal33 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal1 out of 832,812 
Other
 patents

Years Active: 1976-1988

Loading Chart...
34 patents (USPTO):Explore Patents
1. 4719211 - 2,3,4,9-tetrahydro-2-heteroarylalkyl-1H-pyrido(3,4-B)indoles having (1988-01-12),
2. 4638008 - Antiarrhythmic agents (1987-01-20),
3. 4562255 - Substituted bi-alicyclic imides (1985-12-31),
4. 4546193 - Antiarrhythmic cyclooct[b]indoles (1985-10-08),
5. 4540806 - Benzocycloalkane amines (1985-09-10),
6. 4483991 - Hypotensive agents (1984-11-20),
7. 4446323 - Tetra- and hexa-hydropyrrolo(1,2-a)quinoxaline and azaquinoxaline (1984-05-01),
8. 4414389 - 4-Substituted-piperidino carboxamides (1983-11-08),
9. 4400511 - 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids (1983-08-23),
10. 4339579 - 2,6-Bis-(pyrrolopyrazinyl)pyrazines (1982-07-13),
11. 4320057 - Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones (1982-03-16),
12. 4290952 - Aryl-1-mercaptoalkanoylproline and homoproline derivatives (1981-09-22),
13. 4251444 - Thiazepino-[4,3-b]-isoquinoline-1,5-dione derivatives and precursors (1981-02-17),
14. 4225713 - Tetrahydro(1H)pyrazino(1,2-A)azaquinoxalin-5(6H)-ones and derivatives (1980-09-30),
15. 4203987 - 3-[Pyridinylalkyl and (1980-05-20),

Title: Meier E. Freed: A Pioneer in Pharmaceutical Innovations

Introduction

Meier E. Freed, an esteemed inventor based in Paoli, Pennsylvania, has made significant contributions to the field of pharmaceuticals, holding an impressive total of 34 patents. His pioneering work focuses on antihypertensive and antipsychotic agents, showcasing his dedication to advancing medical science and improving patient health outcomes.

Latest Patents

Among his latest inventions is a series of tetrahydropyridoindoles, specifically the 2,3,4,9-tetrahydro-2-heteroarylalkyl-1H-pyrido(3,4-B)indoles. This innovative compound is characterized by a complex formula involving various substituents, demonstrating potential antihypertensive and antipsychotic properties. In addition to this, he has developed a unique group of antiarrhythmic agents, further emphasizing his role in the development of therapeutic solutions for cardiovascular conditions.

Career Highlights

Throughout his career, Meier E. Freed has worked for prominent organizations within the pharmaceutical industry, including American Home Products Corporation. His extensive experience and deep understanding of drug development have led him to be a leading figure in the patenting landscape, influencing both research and clinical applications.

Collaborations

Collaborating with brilliant minds such as John R. Potoski and Magid A. Abou-Gharbia, Freed has fostered a productive environment that encourages innovation and the exchange of ideas. These collaborations have been crucial in propelling his inventions and expanding their implications in the medical field.

Conclusion

Meier E. Freed's contributions to pharmaceutical innovations underscore the importance of creativity and collaboration in medical research. His array of patents not only reflects his ingenuity but also serves as a testament to his commitment to enhancing healthcare through innovative solutions. As the landscape of medicine continues to evolve, Freed remains a vital player in the ongoing quest for new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…